Literature DB >> 35290615

Diagnostic Modalities in Primary Immunodeficiency.

Loveita S Raymond1,2, Jennifer Leiding3, Lisa R Forbes-Satter4,5,6.   

Abstract

As the field of inborn errors of immunity expands, providers continually update and fine-tune their diagnostic approach and selection of testing modalities to increase diagnostic accuracy. Here, we first describe a mechanistic consideration of laboratory testing, highlighting both benefits and drawbacks of currently clinically available testing modalities. Next, we provide methods in evaluation of patients presenting with concern for inborn errors of immunity as defined by the International Union of Immunological Societies 2019 phenotypic categories: primary antibody deficiencies, cellular and humoral immune deficiency, disorders of the innate immune system, and syndrome-associated and primary immune regulation disorders (PIRDs). Using the suggested approach in this paper as a roadmap highlights the importance of thorough history taking and physical examination as the foundation to guide further diagnostic tests. This is followed by enumeration and functional testing. Finally, to determine the underlying molecular etiology-specific genetic panels, chromosomal microarrays, and broad genetic testing (whole exome sequencing or whole genome sequencing) are available.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Diagnostic modalities; Evaluation; Immune dysregulation; Immunodeficiency; Inborn errors of immunity; Testing

Mesh:

Year:  2022        PMID: 35290615     DOI: 10.1007/s12016-022-08933-1

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   10.817


  16 in total

Review 1.  Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: prepared on behalf of the British Committee for Standards in Haematology by a working party of the Haemato-Oncology task force.

Authors:  John M Davies; Michael P N Lewis; Jennie Wimperis; Imran Rafi; Shamez Ladhani; Paula H B Bolton-Maggs
Journal:  Br J Haematol       Date:  2011-11       Impact factor: 6.998

Review 2.  Autoimmune and other cytopenias in primary immunodeficiencies: pathomechanisms, novel differential diagnoses, and treatment.

Authors:  Markus G Seidel
Journal:  Blood       Date:  2014-08-27       Impact factor: 22.113

3.  Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial.

Authors:  Karen L Bride; Tiffaney Vincent; Kim Smith-Whitley; Michele P Lambert; Jack J Bleesing; Alix E Seif; Catherine S Manno; James Casper; Stephan A Grupp; David T Teachey
Journal:  Blood       Date:  2015-10-26       Impact factor: 22.113

4.  Current genetic landscape in common variable immune deficiency.

Authors:  Hassan Abolhassani; Lennart Hammarström; Charlotte Cunningham-Rundles
Journal:  Blood       Date:  2020-02-27       Impact factor: 22.113

5.  Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations.

Authors:  Lisa R Forbes; Tiphanie P Vogel; Megan A Cooper; Johana Castro-Wagner; Edith Schussler; Katja G Weinacht; Ashley S Plant; Helen C Su; Eric J Allenspach; Mary Slatter; Mario Abinun; Desa Lilic; Charlotte Cunningham-Rundles; Olive Eckstein; Peter Olbrich; R Paul Guillerman; Niraj C Patel; Yesim Y Demirdag; Christa Zerbe; Alexandra F Freeman; Steven M Holland; Paul Szabolcs; Andrew Gennery; Troy R Torgerson; Joshua D Milner; Jennifer W Leiding
Journal:  J Allergy Clin Immunol       Date:  2018-08-06       Impact factor: 10.793

6.  Immunoassay Methods and their Applications in Pharmaceutical Analysis: Basic Methodology and Recent Advances.

Authors:  Ibrahim A Darwish
Journal:  Int J Biomed Sci       Date:  2006-09

Review 7.  Radiologic Considerations in Heterotaxy: The Need for Detailed Anatomic Evaluation.

Authors:  Rohit Loomba; Parinda H Shah; Robert H Anderson; Yingyot Arora
Journal:  Cureus       Date:  2016-01-27

8.  Therapeutic options for CTLA-4 insufficiency.

Authors:  David Egg; Ina Caroline Rump; Noriko Mitsuiki; Jessica Rojas-Restrepo; Maria-Elena Maccari; Charlotte Schwab; Annemarie Gabrysch; Klaus Warnatz; Sigune Goldacker; Virginia Patiño; Daniel Wolff; Satoshi Okada; Seiichi Hayakawa; Yoshiaki Shikama; Kenji Kanda; Kohsuke Imai; Manabu Sotomatsu; Makoto Kuwashima; Takahiro Kamiya; Tomohiro Morio; Kazuaki Matsumoto; Takeshi Mori; Yuri Yoshimoto; Ingunn Dybedal; Maria Kanariou; Zeynep Yesim Kucuk; Hugo Chapdelaine; Lenka Petruzelkova; Hanns-Martin Lorenz; Kathleen E Sullivan; Jennifer Heimall; Michel Moutschen; Jiri Litzman; Mike Recher; Michael H Albert; Fabian Hauck; Suranjith Seneviratne; Jana Pachlopnik Schmid; Antonios Kolios; Gary Unglik; Christian Klemann; Scott Snapper; Lisa Giulino-Roth; Michael Svaton; Craig D Platt; Sophie Hambleton; Olaf Neth; Geraldine Gosse; Steffen Reinsch; Dirk Holzinger; Yae-Jean Kim; Shahrzad Bakhtiar; Faranaz Atschekzei; Reinhold Schmidt; Georgios Sogkas; Shanmuganathan Chandrakasan; William Rae; Beata Derfalvi; Hanne Vibeke Marquart; Ahmet Ozen; Ayca Kiykim; Elif Karakoc-Aydiner; Pavlína Králíčková; Godelieve de Bree; Dimitra Kiritsi; Markus G Seidel; Robin Kobbe; Jennifer Dantzer; Laia Alsina; Thais Armangue; Vassilios Lougaris; Philipp Agyeman; Sofia Nyström; David Buchbinder; Peter D Arkwright; Bodo Grimbacher
Journal:  J Allergy Clin Immunol       Date:  2021-06-07       Impact factor: 10.793

9.  Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis.

Authors:  Ivan K Chinn; Olive S Eckstein; Erin C Peckham-Gregory; Baruch R Goldberg; Lisa R Forbes; Sarah K Nicholas; Emily M Mace; Tiphanie P Vogel; Harshal A Abhyankar; Maria I Diaz; Helen E Heslop; Robert A Krance; Caridad A Martinez; Trung C Nguyen; Dalia A Bashir; Jordana R Goldman; Asbjørg Stray-Pedersen; Luis A Pedroza; M Cecilia Poli; Juan C Aldave-Becerra; Sean A McGhee; Waleed Al-Herz; Aghiad Chamdin; Zeynep H Coban-Akdemir; Shalini N Jhangiani; Donna M Muzny; Tram N Cao; Diana N Hong; Richard A Gibbs; James R Lupski; Jordan S Orange; Kenneth L McClain; Carl E Allen
Journal:  Blood       Date:  2018-04-09       Impact factor: 25.476

10.  Diagnostic Immunization with Bacteriophage ΦX 174 in Patients with Common Variable Immunodeficiency/Hypogammaglobulinemia.

Authors:  Lauren L Smith; Rebecca Buckley; Patricia Lugar
Journal:  Front Immunol       Date:  2014-08-29       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.